Filtrera efter Last updated date SelectEfterFöreFrom - To Date Slutdatum Denna vecka Den här månaden Förra veckan Förra månaden Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorPRIMEParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Lämna detta fält tomt Filter Resultat (3828) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Lämna detta fält tomt Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 31 August - 3 September 2020 4 september 2020NewsHumanPharmacovigilanceReferrals PRAC recommends revoking marketing authorisation of ulipristal acetate for uterine fibroids 4 september 2020NewsHumanMedicinesReferrals EMA starts review of dexamethasone for treating adults with COVID-19 requiring respiratory support 2 september 2020NewsHumanCOVID-19MedicinesReferrals EMA receives application for marketing authorisation of Dexamethasone Taw for COVID-19 2 september 2020NewsHumanCOVID-19Medicines Communication@EMA – how are we doing? 10 augusti 2020NewsCorporate Global regulatory workshop on COVID-19 therapeutics #2: agreement on acceptable endpoints for clinical trials 31 juli 2020NewsHumanCOVID-19Research and development Global regulatory workshop on COVID-19 real-world evidence and observational studies 31 juli 2020NewsHumanCOVID-19Research and development Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 July 2020 24 juli 2020NewsHumanCOVID-19BiosimilarsGeneric and hybrid medicinesMedicinesMedicines for use outside the EU Panexcell Clinical Laboratories: suspension of medicines over flawed studies 24 juli 2020NewsHuman First antibody-drug conjugate for multiple myeloma patients with limited treatment options 24 juli 2020NewsHumanMedicines 1 … 80 81 82 83 84 Page 84 of 383 85 86 87 88 … 383
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 31 August - 3 September 2020 4 september 2020NewsHumanPharmacovigilanceReferrals
PRAC recommends revoking marketing authorisation of ulipristal acetate for uterine fibroids 4 september 2020NewsHumanMedicinesReferrals
EMA starts review of dexamethasone for treating adults with COVID-19 requiring respiratory support 2 september 2020NewsHumanCOVID-19MedicinesReferrals
EMA receives application for marketing authorisation of Dexamethasone Taw for COVID-19 2 september 2020NewsHumanCOVID-19Medicines
Global regulatory workshop on COVID-19 therapeutics #2: agreement on acceptable endpoints for clinical trials 31 juli 2020NewsHumanCOVID-19Research and development
Global regulatory workshop on COVID-19 real-world evidence and observational studies 31 juli 2020NewsHumanCOVID-19Research and development
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 July 2020 24 juli 2020NewsHumanCOVID-19BiosimilarsGeneric and hybrid medicinesMedicinesMedicines for use outside the EU
First antibody-drug conjugate for multiple myeloma patients with limited treatment options 24 juli 2020NewsHumanMedicines